Asymmetrical Brain Atrophy in Huntington's Disease: A Post Mortem MRI Study
Bianca Le1, Eardi Lila2, David Hunt3, Daniel Child4, Caitlin Latimer4, Marie Davis1, Suman Jayadev1, Thomas Bird1, Ali Shojaie2, Christine Mac Donald3
1Neurology, 2Biostatistics, 3Neurological Surgery, 4Laboratory Medicine and Pathology, University of Washington
Objective:
In this study, we aim to characterize region-specific gray and white matter differences between Huntington's Disease (HD) patients and controls.
Background:
Huntington’s Disease is a progressive, autosomal dominant, neurodegenerative disease caused by a CAG repeat expansion in the HTT gene. Medium spiny neurons of the striatum are especially vulnerable to the disease, and atrophy of the caudate and putamen can be documented by neuroimaging years before the onset of symptoms.
Design/Methods:
We conducted a post-mortem MRI study of the brains of 15 adults diagnosed with symptomatic Huntington’s Disease and 26 control subjects, aiming to compare the differences in regional grey and white matter volumes between the two groups.
Results:
The study revealed decreased volumes in both grey and white matter in patients with Huntington’s Disease, with the largest effect sizes observed in caudate and putamen. Notably, the atrophy predominantly affected the left hemisphere, particularly impacting grey and white matter regions adjacent to the pars opercularis, precentral, supramarginal, and pars orbitalis gyri, and the lateral orbitofrontal cortex. In the control group, asymmetry stems from larger left hemisphere regions compared to right, whereas an opposite pattern is observed in the Huntington’s Disease group.
Conclusions:
These results suggest progressive, diffuse, and asymmetrical grey and white matter atrophy occurs in Huntington’s Disease. The reasons for this asymmetry remain unknown; however, our study provides a more detailed characterization of previously reported grey and white matter changes in Huntington's Disease, as observed through post-mortem histopathological and MRI studies. Similar findings have been noted in other neurodegenerative diseases, such as frontotemporal dementia, primary progressive aphasia, and possibly Alzheimer's disease.
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.